- Harmful cholesterol levels cut in half with one-time gene editing drug in early trial NBC News
- Scientists have edited a gene that may reduce high cholesterol permanently CNN
- Manage heart disease without pills or diet? Single treatment to cut bad cholesterol in half The Times of India
- Can a One-Time Gene Therapy Lower Cholesterol? Time Magazine
- CRISPR Therapeutics (Nasdaq: CRSP) announces 73% ANGPTL3 drop in Phase 1 CTX310 trial Stock Titan
Harmful cholesterol levels cut in half with one-time gene editing drug in early trial NBC NewsScientists have edited a gene that may reduce high cholesterol permanently CNNManage heart disease without pills or diet? Single treatment to cut bad cholesterol in half The Times of IndiaCan a One-Time Gene Therapy Lower Cholesterol? Time MagazineCRISPR Therapeutics (Nasdaq: CRSP) announces 73% ANGPTL3 drop in Phase 1 CTX310 trial Stock Titan by Soban News (international And National News)